- Home
- CATO vs BNTC Comparison
CATO vs BNTC Comparison
Compare CATO & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATO
- BNTC
- Stock Information
- Founded
- CATO 1946
- BNTC 1995
- Country
- CATO United States
- BNTC United States
- Employees
- CATO N/A
- BNTC N/A
- Industry
- CATO Clothing/Shoe/Accessory Stores
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- CATO Consumer Discretionary
- BNTC Health Care
- Exchange
- CATO Nasdaq
- BNTC Nasdaq
- Market Cap
- CATO 59.2M
- BNTC 366.6M
- IPO Year
- CATO N/A
- BNTC N/A
- Fundamental
- Price
- CATO $2.87
- BNTC $12.74
- Analyst Decision
- CATO
- BNTC Strong Buy
- Analyst Count
- CATO 0
- BNTC 6
- Target Price
- CATO N/A
- BNTC $23.83
- AVG Volume (30 Days)
- CATO 43.0K
- BNTC 219.6K
- Earning Date
- CATO 08-21-2025
- BNTC 05-14-2025
- Dividend Yield
- CATO 6.11%
- BNTC N/A
- EPS Growth
- CATO N/A
- BNTC N/A
- EPS
- CATO N/A
- BNTC N/A
- Revenue
- CATO $642,949,000.00
- BNTC N/A
- Revenue This Year
- CATO N/A
- BNTC N/A
- Revenue Next Year
- CATO N/A
- BNTC N/A
- P/E Ratio
- CATO N/A
- BNTC N/A
- Revenue Growth
- CATO N/A
- BNTC N/A
- 52 Week Low
- CATO $2.19
- BNTC $7.05
- 52 Week High
- CATO $6.70
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- CATO 53.03
- BNTC 40.67
- Support Level
- CATO $2.73
- BNTC $10.91
- Resistance Level
- CATO $2.99
- BNTC $12.74
- Average True Range (ATR)
- CATO 0.18
- BNTC 1.39
- MACD
- CATO -0.02
- BNTC -0.41
- Stochastic Oscillator
- CATO 30.14
- BNTC 29.56
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.